<DOC>
	<DOCNO>NCT00044967</DOCNO>
	<brief_summary>RATIONALE : Identifying gene mutation ( microsatellite instability ) may allow doctor plan effective treatment patient develop colorectal cancer early age . PURPOSE : Genetic trial determine significance gene mutation help predict outcome treatment patient develop stage I , stage II , stage III colorectal cancer early age .</brief_summary>
	<brief_title>Genetic Study Young Patients With Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Evaluate prognostic significance ( e.g. , overall survival ) microsatellite instability ( MSI ) status patient early age-of-onset stage I-III colorectal cancer , assume presence quantitative interaction MSI status family history cancer . - Evaluate development metachronous neoplasms patient population . - Evaluate histologic feature genetic change associate hereditary nonpolyposis colorectal cancer patient population . OUTLINE : This multicenter study . Patients stratify accord family history use Amsterdam II criterion hereditary nonpolyposis colorectal cancer ( positive v negative ) . Patients undergo baseline colonoscopy within 6 month initial curative resection surveillance colonoscopy 1 , 3 , 5 year ( +/- 6 month ) resection . The number , size , location , histology , method removal polyp document time colonoscopy . Patients also undergo microsatellite instability ( MSI ) status test complete family history questionnaire baseline . The prognostic significance family history MSI status evaluate . The individual histologic feature tumor compare MSI status determine predictive value . The histologic feature also correlate outcome determine prognostic significance . Patients may refer genetic counseling . A certificate confidentiality protect identity research participant project issue National Cancer Institute .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Microsatellite Instability</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis stage IIII adenocarcinoma colon rectum Must undergone initial curative resection within past year No colon rectal cancer resection allow definitive T N stag No initial postsurgical surveillance colonoscopy prior study entry Must pathology specimen , representative normal tumor tissue , available submission ACOSOG Central Specimen Bank prior study entry No personal family history familial adenomatous polyposis No recurrent colorectal cancer PATIENT CHARACTERISTICS : Age 18 49 first diagnosis Other Must willing provide family cancer history study team continue followup colonoscopic surveillance No malignancy within past 5 year except completely resected cervical cancer nonmelanoma skin cancer No evidence recurrence prior malignancy PRIOR CONCURRENT THERAPY : Radiotherapy No prior pelvic radiotherapy rectal cancer No concurrent preoperative pelvic radiotherapy rectal cancer Surgery See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stage I colon cancer</keyword>
	<keyword>stage II colon cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage I rectal cancer</keyword>
	<keyword>stage II rectal cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
</DOC>